Barriers and Promise | GenomeWeb

Barriers and Promise

The main stumbling blocks to moving next-gen sequencing advances to the clinic are generating data that show the clinical benefits of such tests and convincing payors to cover those tests, Washington University in St. Louis' Elaine Mardis tells Biome, the BioMed Central blog, in a Q&A.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.